Compare Affirm Holdings Inc (AFRM) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Affirm Holdings Inc vs Summit Therapeutics Inc — how do they compare? Affirm Holdings Inc trades at $77.35 (market cap $25.69B), while Summit Therapeutics Inc trades at $15.28 (market cap $12.06B). The key difference: Affirm Holdings Inc is far larger — about 2.1× Summit Therapeutics Inc's market cap, and Affirm Holdings Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| AFRM | SMMT | |
|---|---|---|
Market Cap | $25.69B | $12.06B |
Sector | Financials | Health |
52-Week High | $92.18 | $26.98 |
52-Week Low | $42.53 | $12.55 |
Enterprise Value | $32.30B | $11.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Affirm Holdings Inc
Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.
Read more on AFRM →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
